In this study, MB showed a much higher RNR inhibitory and antiproliferative potency than HU and overcame the resistance of AML cells to HU, suggesting that MB is a new category of RNR inhibitory compounds with potent activity against AML. This evidence concerns the gene NR2E3 and acute myeloid leukemia.